Therapies at JB

Gastroenterology is one of the five largest therapeutic categories in the Indian pharmaceutical industry. JB is one of the pioneers in this segment and has a diverse and comprehensive portfolio which includes proton pump inhibitors, prokinetics, antacids, laxatives and molecules for hepatobiliary disorders in various dosage forms.

Infectious diseases have been on the rise and with the Covid-19 pandemic the world has taken them even more seriously. At JB we offer a range of anti-infectives in various formulations: topical, oral, injectables, and in various segments: antiparasitic, anti-bacterials and anti-virals. We also have drugs for tackling Covid-19.

Wound care in India is a growing area of concern due to the rising prevalence of co-morbid conditions like diabetes. We believe that it involves both topical and systemic management, so we offer our molecules as anti-infectives, pain management drugs, and proteolytic enzymes for comprehensive wound care. Cadexomer iodine, one of our leading products in this segment, aids healing in a range of acute and chronic wounds.

Neonatology and Paediatrics are segments dedicated to the big needs of ‘little’ people. Under the child health and neonatal care segments, we have a range of product offerings covering allergies, gastroenterology and anti-infectives. In this segment, we specially focus more on drug delivery and efficacy so that dosage forms are suited to the needs of children.

It has been observed that the risk of malnutrition increases as women enter adulthood. Maternal malnutrition increases the risk of maternal mortality as well as child-birth defects. Among young women in developing countries, reproductive tract infections are a public health problem. From multivitamins to pain-alleviating molecules, iron supplements, anti-infectives and supplements for bone health, our gynaecology portfolio is dedicated to the varied needs of women’s health.

Dental care is a segment that has both wellness products as well as products used in the treatment of oral diseases. Most oral health conditions are largely preventable and can be treated in their early stages. JB offers a wide range of solutions for pain management, infection treatment, wound healing and mouth-ulcer gels. Our broad dental care portfolio caters to the varied requirements of dental care.

Due to poor and restricted diets, dominance of packaged and processed foods lacking in nutrients, menstrual iron losses and increased iron requirements by developing foetuses, women and children in developing countries are overwhelmingly anaemic. Statistics are similar in men too, with one in four men being anaemic. We offer nutritional supplements for restoring the balance of essential nutrients in the body, improving bone health and providing quality products for holistic wellness.

Hypertension is a serious medical condition affecting over a billion people across the world. JB offers a wide range of anti-hypertensive products alongside with kidney care. We are the leader in the Calcium Channel Blockers (CCB) segment, with our brand Cilacar being the #1 CCB brand in the Indian market. Our brand Nicardia is the go-to brand for resistant blood pressure management. We also offer β-Blockers, Fixed Dose Combinations (FDCs) of CCB and Angiotensin Receptor Blockers, FDCs of CCB and Diuretics, Statins, Anti-platelets etc.

Diabetes is a global epidemic affecting 463 million people worldwide. India is home to the second-largest population of diabetic individuals in the world. To address this requirement, JB has a comprehensive product portfolio including Dipeptidyl peptidase-4 (DPP-4) inhibitor, FDCs of DPP-4 inhibitor + Metformin & Sodium-glucose Co-transporter-2 (SGLT2) inhibitor, and FDCs of SGLT2 inhibitor + Metformin.

10% of the world population is affected by chronic kidney disease (CKD), and millions die each year because they do not have access to affordable treatment. Chronic kidney disease can be treated with early diagnosis and treatment. JB offers enhanced comprehensive renal care with novel products which aim to delay disease progression and offers sustained protection in CKD. Our Nephrology basket includes novel medicines such as Midodrine, Moxonidine, Alpha Ketoanalogues, Liposomal Ferric Pyrophosphate, and Sodium Bicarbonate.

Respiratory diseases including asthma, COPD, acute lower respiratory tract infections, tuberculosis, and lung cancer impose an immense worldwide health burden. JB has a respiratory portfolio that includes antihistaminics, leukotriene receptor antagonists, mucolytics, cough suppressants, corticosteroids, antibiotics, and anti-viral drugs.

International Law describes ‘pain management’ as a human right. It is estimated that 20% of adults suffer from pain globally and 10% are newly diagnosed with chronic pain each year. To address this growing concern we have certain key analgesics and anti-inflammatory drugs. Our analgesic basket includes medicines such as non-steroidal anti-inflammatory drugs (NSAIDs), anti-pyretics, and anti-spasmodics amongst many more.

The skin is the body’s largest organ and first-line barrier against several noxious environmental pollutants and stimuli. Skin diseases are the fourth most common cause of all human diseases, affecting almost one‐third of the world’s population. JB offers certain novel products such as Cadexomer Iodine gels and ointments, Paraffin cream and many others for managing varied skin disorders.

Viral diseases are extremely widespread infections. Viruses cause familiar infectious diseases such as the common cold, flu, warts and also severe illnesses such as HIV/AIDS, Ebola, and COVID-19. Viral infections have spread globally, causing a spectrum of diseases that range from self-limited febrile illness to permanent severe disability, congenital anomalies, and early death. With patients at the core, we at JBCPL have launched innovative anti-viral medicines for managing a range of viral diseases. Some of our anti-viral products include Favipiravir and Oseltamivir.

Lozenges are one of the most widely used dosage forms as they provide a palatable means of drug administration. The key benefits of medicated lozenges are: they increase the retention time of the dosage form in the oral cavity which increases bioavailability, reduces gastric irritation, and by-passes first-pass metabolism. JB is the 3rd largest manufacturer in the world and offers lozenges in myriad shapes, flavours and forms in both medicated and herbal forms. We produce hard-candy lozenges, soft-centre lozenges and powder-filled lozenges for varied medical needs.

Contrast materials, also known as contrast agents or contrast media, are utilized in imaging tests to increase the diagnostic value. Contrast materials are not dyes that stain interior organs permanently. These are compounds that alter the way X – Rays or other imaging equipment interact with the body for a short period of time. JB PHARMA is one of the leading players in Contrast media with a wide range of products.